|
CEP120 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.579800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.987950E-04 |
| Normal-vs-Stage2 |
3.205900E-02 |
| Normal-vs-Stage3 |
2.363600E-01 |
| Normal-vs-Stage4 |
8.019200E-01 |
| Stage1-vs-Stage2 |
6.745400E-01 |
| Stage1-vs-Stage3 |
6.109900E-02 |
| Stage1-vs-Stage4 |
2.956800E-03 |
| Stage2-vs-Stage3 |
1.579190E-01 |
| Stage2-vs-Stage4 |
3.030100E-02 |
| Stage3-vs-Stage4 |
2.326000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.983400E-04 |
| Normal-vs-AfricanAmerican |
2.897200E-01 |
| Normal-vs-Asian |
3.462600E-01 |
| Caucasian-vs-AfricanAmerican |
9.418100E-04 |
| Caucasian-vs-Asian |
9.005000E-01 |
| AfricanAmerican-vs-Asian |
1.464770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.075050E-03 |
| Normal-vs-Female |
1.044640E-01 |
| Male-vs-Female |
1.792990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.704810E-01 |
| Normal-vs-Age(41-60Yrs) |
3.339900E-03 |
| Normal-vs-Age(61-80Yrs) |
5.115400E-03 |
| Normal-vs-Age(81-100Yrs) |
5.069200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.783800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.784320E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.572200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.895400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.221800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.792600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.045770E-02 |
| Normal-vs-Grade 2 |
1.61389999999706E-05 |
| Normal-vs-Grade 3 |
7.840500E-02 |
| Normal-vs-Grade 4 |
2.712800E-01 |
| Grade 1-vs-Grade 2 |
9.850800E-01 |
| Grade 1-vs-Grade 3 |
2.655800E-01 |
| Grade 1-vs-Grade 4 |
2.721800E-02 |
| Grade 2-vs-Grade 3 |
5.140600E-03 |
| Grade 2-vs-Grade 4 |
1.70810999999826E-05 |
| Grade 3-vs-Grade 4 |
1.754040E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63809998898756E-09 |
| Normal-vs-ccB subtype |
8.937400E-01 |
| ccA subtype-vs-ccB subtype |
1.12910003569056E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.257100E-03 |
| Normal-vs-N1 |
2.018800E-01 |
| N0-vs-N1 |
5.048100E-02 |
|
|
